✨ Free AI Report
Aldeyra Therapeutics, Inc.: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Research Preview Aldeyra Therapeutics, Inc.
Research Preview

Aldeyra Therapeutics, Inc.: Business Overview, Financials & Competitive Analysis

Aldeyra Therapeutics is a clinical-stage biotechnology company focused on discovering and developing innovative therapies for immune-mediated and metabolic diseases. The company's proprietary RASP (reactive aldehyde s...

Analyst-debate audio for Aldeyra Therapeutics, Inc.

AskCyborg analysts argue the bull and bear cases for Aldeyra Therapeutics, Inc. across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
Aldeyra Therapeutics, Inc. OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below
6/ 10Solid

Cyborg Score thesis

RASP modulator platform provides differentiated approach to immune-mediated diseases with reproxalap approaching...

Read the full analyst-debate transcript →
Industry Biotechnology - Immunology & Ophthalmology Therapeutics
3 named competitors
4 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: September 14, 2026
AI-Verified Research
30+ Page Report

Get the Latest Aldeyra Therapeutics, Inc. Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Aldeyra Therapeutics, Inc. Overview

Pro stress-test →

Aldeyra Therapeutics is a clinical-stage biotechnology company focused on discovering and developing innovative therapies for immune-mediated and metabolic diseases. The company's proprietary RASP (reactive aldehyde species) modulator platform targets pre-cytokine inflammation mediators with the goal of optimizing multiple pathways while minimizing toxicity.

Strategic Profile

Pro stress-test →

Aldeyra's competitive advantage lies in its differentiated RASP platform approach versus traditional single-target inhibition. The company has positioned itself as a developer of first-in-class treatments across ophthalmology and systemic disease areas, with multiple assets in clinical development stages.

Competitive Landscape

Pro stress-test →

Aldeyra competes in the ophthalmology and immune-mediated disease therapeutics space against larger pharma and specialty biotech companies. Key competitors include companies developing dry eye treatments (topical and systemic approaches) and retinal disease therapies. Aldeyra's RASP platform differentiation and first-in-class potential position it favorably in underserved indication areas.

Industry Context

Aldeyra Therapeutics, Inc. operates in Biotechnology - Immunology & Ophthalmology Therapeutics.

Key facts

Founded: 2004 · Headquarters: Lexington, MA, United States

What the analysts stress-tested

The top findings that survived the multi-agent debate for Aldeyra Therapeutics, Inc..

+2 more stress-tested counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

Get alerted when Aldeyra Therapeutics, Inc. has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

RESTASIS/CequaCyclosporine-based dry eye treatment→XiidraLFA-1 antagonist for dry eye disease→OcuSense/OCS-01Sustained-release dry eye therapeutic→

Compare Aldeyra Therapeutics, Inc. with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Aldeyra Therapeutics, Inc. operates in Biotechnology - Immunology & Ophthalmology Therapeutics. See how the rest of the sector scores on the Cyborg framework.

Browse Biotechnology - Immunology & Ophthalmology Therapeutics research →
NEW · MCP server

Ask your AI assistant about Aldeyra Therapeutics, Inc.

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Aldeyra Therapeutics, Inc. and its top competitor on Cyborg Score”
“What did Aldeyra Therapeutics, Inc. do this quarter?”
“Is Aldeyra Therapeutics, Inc. a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg builds confidence

⚔

Analyst debate, not single-author opinion

Every report is stress-tested by a panel of AI analysts arguing across 11 dimensions. The output is the part of the case that survived pushback.

📊

Recalibrated weekly

The Cyborg Score is recomputed weekly against fresh data. Recent material developments are continuously tracked and surfaced.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The same company gets the same score from any analyst running the framework.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, news flow, and proprietary analyst signals. Read the methodology →

Frequently asked questions

What does Aldeyra Therapeutics, Inc. do?+
Aldeyra Therapeutics is a clinical-stage biotechnology company focused on discovering and developing innovative therapies for immune-mediated and metabolic diseases. The company's proprietary RASP (reactive aldehyde s...
What is Aldeyra Therapeutics, Inc.'s Cyborg Score?+
Aldeyra Therapeutics, Inc. has a Cyborg Score of 6/10 (Solid). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Aldeyra Therapeutics, Inc.'s main competitors?+
Named competitors include RESTASIS/Cequa, Xiidra, OcuSense/OCS-01. The full competitive landscape is in the AskCyborg report.
How can I get the full Aldeyra Therapeutics, Inc. research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Aldeyra Therapeutics, Inc. research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Aldeyra Therapeutics, Inc. over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

Top-scored companies on AskCyborg

The strongest performers across the analyst-debate framework.

9Advantest Corporation9Anthropic9Apple Inc.9Applied Materials, Inc.9Arista Networks9Aritzia Inc.9ASML Holding N.V.9BAE Systems plc9Barrick Mining Corporation9Berkshire Hathaway Inc.